IAP perspectives on measles and rubella elimination strategies

Indian Pediatrics

Volumn 51, Issue 9, 2014, Pages 719-722

  Vashishtha, Vipin M ^a,b   Yewale, Vijay N ^a   Bansal, C P ^a   Mehta, Pravin J ^a  

^a Indian Academy of Pediatrics   (India)

^b IAP Advisory Committee on Vaccines Immunization Practices   (India)

Author keywords

Measles mumps rubella vaccine; Prevention; Universal immunization program

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; RUBELLA VACCINE;

ARTICLE; DISEASE ELIMINATION; HUMAN; MEASLES; MEASLES VACCINATION; MUMPS; RUBELLA; SYSTEMATIC REVIEW (TOPIC); TIME; ADOLESCENT; CHILD; FEMALE; IMMUNIZATION; INDIA; INFANT; MALE; MASS IMMUNIZATION; ORGANIZATION; PEDIATRICS; PRESCHOOL CHILD;

ACADEMIES AND INSTITUTES; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INDIA; INFANT; MALE; MASS VACCINATION; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; PEDIATRICS; RUBELLA;

EID: 84918768602     PISSN: 00196061     EISSN: 09747559     Source Type: Journal    
DOI: 10.1007/s13312-014-0488-7     Document Type: Article

References (21)

1. Government of India, Ministry of Health and Family Welfare (Immunization Division). ICMR Expert Group Recommendations on inclusion of Rubella vaccination, ICMR, May, 2012.
2. Dewan P, Gupta P. Burden of congenital rubella syndrome (CRS) in India: A systematic review. Indian Pediatr. 2012;49:377–99.
3. John TJ. An outbreak of mumps in Thiruvananthapuram district. Indian Pediatr. 2004;41:298–300.
4. Geeta MG, Kumar PK. Mumps — need for urgent action. Indian Pediatr 2004;41:1181–2.
5. Ghatage ST, Kakade GM. An outbreak of mumps meningoencephalitis in Sangli district. Indian Pediatr. 2007;44:235.
6. Jeevan M, Sambantham S, Thangam M. Characterisation of mumps virus genotype C among patients with mumps in India. Indian J Med Microbiol. 2013;31:290–2.
7. Mishra B, Pujhari SK, Dhiman V, Mahalakshmi P, Bharadwaj A, Pokhrel S, et al. Genotyping and subtyping of mumps virus isolates from the Indian subcontinent. Arch Virol. 2013;158:2359–63.
8. Vaidya SR, Chowdhury DT, Kumbhar NS, Tomar R, Kamble MB, Kazi MI. Circulation of two mumps virus genotypes in an unimmunized population in India. J Med Virol. 2013;85:1426–32.
9. IDsurv. Infectious Disease Surveillance Project. Available from: www.idsurv.org
10. WHO Position Paper, Mumps Virus Vaccines. Wkly Epidemiol Rec. 2007;82:49–60.
11. Wang W, Zhu Y, Wu H, Jiao Y, Van Halm-Lutterodt N, Li W. IL-6 and IFNa are elevated in severe mumps cases: A study of 960 mumps patients in China. J Infect Dev Ctries. 2014;8:208–14.
12. Background material for NTAGI Standing Technical Sub-Committee (STSC) Meeting on “Potential Strategies for the Control of Rubella and CRS Burden in India.” February 26, 2014; Indian Council of Medical Research, New Delhi.
13. Status Report on Progress towards Measles and Rubella Elimination. SAGE Working Group on Measles and Rubella (17 October 2013) Available from: http://www.who.int/immunization/sage/meetings/2013/november/Status_Report_Measles_Rubella21Oct2013_FINAL.pdf Accessed on May 19, 2014.
14. Measles, Mumps and Rubella Vaccines. In: Vashishtha VM, Choudhury P, Bansal CP, Yewale VN, Agarwal R. editors. IAP Guidebook on Immunization 2013–2014. National Publication House, Indian Academy of Pediatrics, Gwalior, 2014.
15. Schoub BD, Johnson S, McAnerney JM, Wagstaff LA, Matsie W, Reinach SG, et al. Measles, mumps, and rubella immunization at nine months in a developing country. Pediatr Infect Dis J. 1990; 9:263–7.
16. Giammanco G, Li Volti S, Salemi I, Giammanco Bilancia G, Mauro L. Immune response to simultaneous administration of a combined measles, mumps and rubella vaccine with booster doses of diphtheria-tetanus and poliovirus vaccine. Eur J Epidemiol. 1993; 9:199–202.
17. Singh R, John TJ, Cherian T, Raghupathy P. Immune response to measles, mumps and rubella vaccine at 9, 12 and 15 months of age. Indian J Med Res. 1994;100:155–9.
18. Forleo-Neto E, Carvalho ES, Fuentes IC, Precivale MS, Forleo LH, Farhat CK. Seroconversion of a trivalent measles, mumps, and rubella vaccine in children aged 9, 12 and 15 months. Vaccine. 1997;15:1898–901.
19. Klinge J, Lugauer S, Korn K, Heininger U, Stehr K. Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9–11, 12–14 or 15–17 months of age. Vaccine. 2000;18:3134–40.
20. Yadav S, Thukral R, Chakarvarti A. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age. Indian J Med Res. 2003;118:183–6.
21. Goh P, Lim FS, Han HH, Willems P. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella (MMRV) vaccine in healthy children from 9 months of age. Infection 2007;35:326–33.